These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34705101)

  • 21. Comparison of fractional erbium:YAG laser-assisted tranexamic acid delivery alone and in combination with oral tranexamic acid in melasma.
    Botsali A; Esme P; Erbil H; Caliskan E
    Lasers Med Sci; 2022 Sep; 37(7):2823-2830. PubMed ID: 35347552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
    Alsaad SM; Ross EV; Mishra V; Miller L
    Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective randomized comparative study on 60 Indian patients of melasma, comparing pixel Q-switched NdYAG (1064 nm), super skin rejuvenation (540 nm) and ablative pixel erbium YAG (2940 nm) lasers, with a review of the literature.
    Garg S; Vashisht KR; Makadia S
    J Cosmet Laser Ther; 2019 Aug; 21(5):297-307. PubMed ID: 31010346
    [No Abstract]   [Full Text] [Related]  

  • 24. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
    Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
    Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significant therapeutic response to cysteamine cream in a melasma patient resistant to Kligman's formula.
    Kasraee B; Mansouri P; Farshi S
    J Cosmet Dermatol; 2019 Feb; 18(1):293-295. PubMed ID: 30537063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative Study of Combination of Oral Tranexamic Acid With Modified Kligman's Formula Versus Oral Tranexamic Acid With Azelaic Acid 15% in the Treatment of Melasma.
    Singh R; Maheshwari P; Madke B; Singh A; Jawade S
    Cureus; 2023 Jun; 15(6):e40908. PubMed ID: 37496546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Randomized Study to Evaluate the Efficacy of Oral Tranexamic Acid, Modified Kligman's Formula, and Placebo Cream in Melasma.
    Prathyoosha S; Ananditha K; Narayana Rao T; Gopal KVT; Krishnam Raju PV
    Indian Dermatol Online J; 2024; 15(5):787-793. PubMed ID: 39359301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A clinical study of melasma and a comparison of the therapeutic effect of certain currently available topical modalities for its treatment.
    Sardesai VR; Kolte JN; Srinivas BN
    Indian J Dermatol; 2013 May; 58(3):239. PubMed ID: 23723484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of intralesional steroid injection in the treatment of melasma.
    Nassar AAE; Ibrahim AM; Mahmoud AA
    J Cosmet Dermatol; 2021 Mar; 20(3):862-867. PubMed ID: 32741075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-fluence Q-switched Nd: YAG 1064-nm laser and intense pulsed light for the treatment of melasma.
    Vachiramon V; Sirithanabadeekul P; Sahawatwong S
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1339-46. PubMed ID: 25413592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Safety of Ablative Fractional Laser in Melasma: A Meta-analysis and Systematic Review.
    Zhao S; Wang M; Lai X; Yan Y
    Lasers Med Sci; 2024 Feb; 39(1):71. PubMed ID: 38379033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel technique to treat melasma in Chinese: The combination of 2940-nm fractional Er:YAG and 1064-nm Q-switched Nd:YAG laser.
    Tian WC
    J Cosmet Laser Ther; 2016; 18(2):72-4. PubMed ID: 26836057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of 1927 nm fractional Thulium fiber laser for the treatment of melasma: a retrospective study of 100 patients.
    Kurmuş G; Tatlıparmak A; Aksoy B; Koç E; Aşiran Serdar Z; Ergin C
    J Cosmet Laser Ther; 2019; 21(7-8):408-411. PubMed ID: 31690148
    [No Abstract]   [Full Text] [Related]  

  • 34. Laser therapy in the treatment of melasma: a systematic review and meta-analysis.
    Lai D; Zhou S; Cheng S; Liu H; Cui Y
    Lasers Med Sci; 2022 Jun; 37(4):2099-2110. PubMed ID: 35122202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of efficacy and safety of tranexamic acid mesotherapy versus oral tranexamic acid in patients with melasma undergoing Q-switched fractional 1064-nm Nd:YAG laser: A blinded RCT and follow-up.
    Behrangi E; Shemshadi M; Ghassemi M; Goodarzi A; Dilmaghani S
    J Cosmet Dermatol; 2022 Jan; 21(1):279-289. PubMed ID: 34724323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The treatment of melasma with topical creams alone, CO2 fractional ablative resurfacing alone, or a combination of the two: a comparative study.
    Trelles MA; Velez M; Gold MH
    J Drugs Dermatol; 2010 Apr; 9(4):315-22. PubMed ID: 20514787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined treatment of melasma involving low-fluence Q-switched Nd:YAG laser and fractional microneedling radiofrequency.
    Kwon HH; Choi SC; Jung JY; Park GH
    J Dermatolog Treat; 2019 Jun; 30(4):352-356. PubMed ID: 30160539
    [No Abstract]   [Full Text] [Related]  

  • 38. Periorbital rejuvenation with fractional 1,550-nm ytterbium/erbium fiber laser and variable square pulse 2,940-nm erbium:YAG laser in Asians: a comparison study.
    Wattanakrai P; Pootongkam S; Rojhirunsakool S
    Dermatol Surg; 2012 Apr; 38(4):610-22. PubMed ID: 22268427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Q-switched Nd: YAG laser versus trichloroacetic acid peeling in the treatment of melasma among Egyptian patients.
    Moubasher AE; Youssef EM; Abou-Taleb DA
    Dermatol Surg; 2014 Aug; 40(8):874-82. PubMed ID: 25068546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of 1064 nm Q-switched Nd:YAG laser and Jessner peeling in melasma treatment.
    Ertam Sagduyu I; Marakli O; Oraloglu G; Bulut Okut E; Unal I
    Dermatol Ther; 2022 Dec; 35(12):e15970. PubMed ID: 36346028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.